pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,782 catalysts · 4,779 phase readout · 2,339 8k filing · 285 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings285
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05966519: ROSA Knee Intraoperative Planning Flexibility Study

    Sponsor: Zimmer Biomet. Phase: . Conditions: Osteo Arthritis Knee, Rheumatoid Arthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04648930: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies

    Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Allergic Rhinitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05185128: Neural Basis of Social Cognition Deficits

    Sponsor: Loma Linda University. Phase: NA. Conditions: Autism Spectrum Disorder, Psychosis, Social Communication

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03439865: Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis

    Sponsor: University of Alabama at Birmingham. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis (Diagnosis)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07389967: Nutrition Awareness Among Women With Non-Metastatic Breast Cancer

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: NA. Conditions: Breast Cancer, Breast Cancer Metastatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07487467: Autologous SVF Therapy for Type 2 Diabetes

    Sponsor: Kaiser Clinic and Hospital. Phase: NA. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06630000: Focused Acceptance and Commitment Therapy (FACT)

    Sponsor: Children's Mercy Hospital Kansas City. Phase: NA. Conditions: Pediatric Feeding Disorders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07436507: Effects of a Combined Home-Based Exercise Program on Dual-Task Gait Performance, EEG Markers of Cognitive-Motor Control, and Pain in Females With Primary Dysmenorrhea: A Randomized Controlled Trial

    Sponsor: University of Sharjah. Phase: NA. Conditions: Dysmenorrhea Primary

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07395492: App-Based Education and Low-Residue Diet for Colonoscopy Preparation

    Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Bowel Preparation Solution

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07018336: Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients

    Sponsor: Istinye University. Phase: NA. Conditions: Hemiplegia, Stroke, Upper Extremity Dysfunction

    full page →ctgov ↗
    ›TEMPORARILY_NOT_AVAILABLEphase readoutNCT06383611: Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

    Sponsor: Osteal Therapeutics, Inc.. Phase: . Conditions: Prosthetic-joint Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03838536: Synergistic Activity of Human Milk Nutrients and Infant Cognition

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Breastfeeding, Exclusive

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01048736: Investigating Fitness Interventions in the Elderly (INFINITE)

    Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Obesity, Older Adults, Sedentary

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07029711: A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

    Sponsor: Pfizer. Phase: PHASE3. Conditions: Severe Alopecia Areata

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07447271: Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block

    Sponsor: Pusan National University Yangsan Hospital. Phase: NA. Conditions: Cervical Radiculopathy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT01898494: Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

    Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Oropharynx

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07394166: Balancing Emotions and Electronics: A Pilot Intervention for Preschoolers

    Sponsor: Boston Children's Hospital. Phase: NA. Conditions: Screen Media Use

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07491666: Effects of Neuromuscular Exercises on Motor Skills in Girls

    Sponsor: University of Novi Sad. Phase: NA. Conditions: Motor Skills, Locomotor Activity, Objective Control Skills

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07173166: Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy

    Sponsor: Instituto de Investigacion Sanitaria INCLIVA. Phase: NA. Conditions: Hematologic Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT00024622: PET Scanning in Parkinson s Disease

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: Schizophrenia, Parkinson's Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07486102: A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy, Hepatic Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06853002: Deep Breathing Exercises and Incentive Spirometry After Rib Fracture

    Sponsor: Samsun University. Phase: NA. Conditions: Rib Fractures, Oxygenation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07495137: The Improvement Effect of Real-time Artificial Intelligence Assisted Identification of Bleeding Points on Hemostasis Efficiency in Endoscopic Submucosal Dissection

    Sponsor: Qilu Hospital of Shandong University. Phase: NA. Conditions: Endoscopic Submucosal Dissection, Endoscopic Submucosal Dissection (ESD)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07145437: Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

    Sponsor: Clinique Sainte Clotilde. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05729945: Catholic Health Initiatives (CHI) St. Joseph's Children Home Visiting Longitudinal Study

    Sponsor: University of New Mexico. Phase: NA. Conditions: Child Development, Child Behavior, Child Abuse, Child Neglect, Parenting, Delinquency, Criminal Behavior

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05746039: Feasibility of Semaglutide in Advanced Lung Disease

    Sponsor: University of Pennsylvania. Phase: PHASE1. Conditions: Obesity, Interstitial Lung Disease, Chronic Obstructive Pulmonary Disease, Sarcoidosis, Pulmonary, Pulmonary Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05756777: A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: Acute Myeloid Leukemia (AML)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06282601: STUDY OF THE EFFECT OF RHYTHMIC AND NON-RHYTHMIC MUSICAL PRIMING ON THE SYNTAX CAPACITY OF PRESBYACOUSTIC OLDER ADULTS

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Presbyacousie

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07114601: A Study of LY4257496 in Participants With Cancer (OMNIRAY)

    Sponsor: Eli Lilly and Company. Phase: PHASE1. Conditions: Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm, Endometrial Neoplasms, Neoplasm Metastasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05929001: Lymphedema Specific PROs for Risk Assessment, Prevention and Early Detection

    Sponsor: University of Miami. Phase: . Conditions: Lymphedema

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03136601: Percutaneous Tibial Nerve Stimulation Maintenance: Monthly Therapy or Per Patient Requested Need

    Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. Phase: NA. Conditions: Overactive Bladder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05306301: Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients

    Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto. Phase: PHASE2. Conditions: Chemotherapy, Leukemia, Acute Lymphoblastic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07203001: A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE2. Conditions: Still´s Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06410001: CE-STAND: Cervical Epidural STimulation After Neurologic Damage

    Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Spinal Cord Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07535801: Recording Stress Biomarkers in Autism Spectrum Disorders

    Sponsor: Universite Cote d'Azur. Phase: . Conditions: Autism Spectrum Disorder With Intellectual Deficiency

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06149481: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

    Sponsor: Abiomed Inc.. Phase: NA. Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07336030: Effect of Baduanjin Exercise in Diabetic Patients

    Sponsor: Cairo University. Phase: NA. Conditions: Diabetes Mellitus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06623630: Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

    Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01375530: Screening Volunteers for Clinical Trials

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Screening

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07457528: Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

    Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Resectable Esophageal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07550465: Study of QLS1410 in the Treatment of Primary Aldosteronism.

    Sponsor: Qilu Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Primary Aldosteronism

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06682767: A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)

    Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Cerebral Blood Flow, APOE 4

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03835767: Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Milk and/or Peanut Allergy

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07380867: Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.

    Sponsor: Seoul St. Mary's Hospital. Phase: NA. Conditions: Colorectal Cancer, Endoscopic Tattoo of Suspected Colon Cancer, Indocyanine Green (ICG)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05852600: Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents

    Sponsor: George Washington University. Phase: NA. Conditions: Hiv, Sexual Health

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05843565: Standard Versus Hyperangulated Video Laryngoscopy Blades for Intubation in Neonates and Small Infants

    Sponsor: American University of Beirut Medical Center. Phase: NA. Conditions: Intubation; Difficult or Failed

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06575400: A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People

    Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD

    Sponsor: University of California, Davis. Phase: NA. Conditions: ADHD

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05467800: Study of Canakinumab in Patients With Myelofibrosis

    Sponsor: John Mascarenhas. Phase: PHASE2. Conditions: Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF, Post-polycythemia Vera Related Myelofibrosis, PV-MF

    full page →ctgov ↗
    ← prev
    page 4 of 96
    next →